Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-10-03 Opioid substitution therapy
| Methadone |
|
Formulary
|
For use under specialist addiction services |
 NICE TA114: Methadone and bupreorphine for the management of opioid dependence |
|
| Buprenorphine |
|
Formulary
|
For use under specialist addiction services |
|
NICE TA114: Methadone and buprenorphine for the management of opioid dependence |
|
|
Links
- Administration of depot antipsychotic injections during COVID-19 in stable adult patients
NICE CG52: Opioid detoxification (Drug misuse)- NICE TA114: Drug misuse - methadone and buprenorphine
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA114: Methadone and bupreorphine for the management of opioid dependence
- NICE TA115: Drug misuse - Naltrexone for the management of opioid dependence
- Smoking Cessation Services Guidance and Guidelines